M.D. Anderson Cancer Center: all 3,044 studies

Page 23 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal CancerCompletedNCT02217865
• Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by SurgeryActive, not recruitingNCT02210117Early Phase 1
• Adoptive Therapy Using Antigen-Specific CD4 T-CellsWithdrawnNCT02210104Phase 1
• Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus InfectionActive, not recruitingNCT02210078Phase 2
• mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and OvarianActive, not recruitingNCT02208375Phase 1
• Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved ImagingCompletedNCT02203136
• Yoga Program for Lung Cancer Patients and CaregiversCompletedNCT02196844Not applicable
• Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family MembersActive, not recruitingNCT02194387Not applicable
• Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)WithdrawnNCT02194374Phase 1
• A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer TherapyWithdrawnNCT02193672Phase 1
• SINF: Peripheral Neuropathy in Cancer SurvivorsWithdrawnNCT02168894Phase 1/2
• Undetected Sleep Apnea in the Postanesthesia Acute Care Unit (PACU)Status unknownNCT02166879
• Use of Navigated Transcranial Magnetic Stimulation (nTMS) in Generated Motor and Language Mapping to Evaluate Brain Recovery Following SurgeryWithdrawnNCT02165995Not applicable
• Reward Sensitivity and Pharmacotherapy for Smoking CessationActive, not recruitingNCT02162849Phase 4
• Effects of Meditation on Cognitive Function and Quality of LifeCompletedNCT02162329Not applicable
• Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer PatientsStatus unknownNCT02160366
• Contrast-enhanced MRI in Detecting Benign and Malignant Liver LesionsActive, not recruitingNCT02156739Not applicable
• Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsCompletedNCT02152943Phase 1
• Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)Active, not recruitingNCT02152254Phase 2
• Using Multimedia Approaches to Communicate Probabilities in Patient Decision Aids for Low-Literacy Populations: Randomized TrialCompletedNCT02151032
• Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)TerminatedNCT02141477Phase 1
• Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and CancerTerminatedNCT02140021Not applicable
• LDE225 + Everolimus in Advanced Gastroesophageal AdenocarcinomaCompletedNCT02138929Phase 1
• Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic LeukemiaActive, not recruitingNCT02131584Phase 2
• Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in MyelomaWithdrawnNCT02114502Phase 2
• T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate CancerCompletedNCT02113657Early Phase 1
• Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell LymphomaActive, not recruitingNCT02106988Phase 2
• High-Resolution Microendoscopy to Guide Hysteroscopic Tumor ResectionWithdrawnNCT02095847Phase 2
• Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT02095834Phase 1
• Regorafenib and Cetuximab in Patients With Advanced MalignancyCompletedNCT02095054Phase 1
• Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290CompletedNCT02093546
• Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell TransplantCompletedNCT02083250Phase 1
• The Role of Lifestyle Factors in Breast Cancer-Related OutcomesActive, not recruitingNCT02079662Not applicable
• Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon CarcinomaCompletedNCT02062749Phase 1
• PP-Gemcitabine & External Beam Radiation-SarcomasCompletedNCT02046304Phase 1
• Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)WithdrawnNCT02044601Phase 1/2
• Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian CancerActive, not recruitingNCT02043158
• MLN9708 and Vorinostat in Patients With Advanced p53 Mutant MalignanciesCompletedNCT02042989Phase 1
• An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy)WithdrawnNCT02029612Not applicable
• IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)WithdrawnNCT02028039Phase 2
• Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaActive, not recruitingNCT02007044Phase 2
• Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural MalignancyCompletedNCT01998529Phase 1
• Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple MyelomaTerminatedNCT01985477Phase 1
• Widespread vs. Selective Screening for Hepatitis B Infection Prior to ChemotherapyCompletedNCT01970254
• APPSPIRE App in Preventing Students From SmokingCompletedNCT01967082Not applicable
• Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV MelanomaActive, not recruitingNCT01955460Phase 1
• Hatha Yoga in Lung Cancer CouplesTerminatedNCT01952860Not applicable
• Hypofractionated Proton Beam Therapy for Localized Prostate CancerActive, not recruitingNCT01950351Phase 2
• Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma PeritoneiActive, not recruitingNCT01946854Not applicable
• Rituximab + GM-CSF in Patients With Follicular B-Cell LymphomaCompletedNCT01939730Phase 2
• A Feasibility Study of Prophylactic White Blood Cell TransfusionsCompletedNCT01932710Phase 2
• Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)CompletedNCT01926665Phase 1
• Physical Activity in Promoting Smoking Cessation in African AmericansActive, not recruitingNCT01915810Not applicable
• Prophylactic Salpingectomy With Delayed OophorectomyActive, not recruitingNCT01907789Not applicable
• STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the BrainCompletedNCT01904123Phase 1
• Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)CompletedNCT01895842Phase 1
• Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRITerminatedNCT01895829Early Phase 1
• Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal CancerActive, not recruitingNCT01893307Phase 3
• Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)TerminatedNCT01891981Phase 1
• Selective Image Guided Resection of Axillary Lymph NodesCompletedNCT01880645Not applicable
• Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell LymphomaActive, not recruitingNCT01880567Phase 2
• Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant DiseaseWithdrawnNCT01864070Phase 1
• Neuropathic Pain in Head and Neck CancerStatus unknownNCT01846286
• Testing Accountability in Patient AdherenceStatus unknownNCT01844557
• Outcome of Colonoscopy Screening and SurveillanceStatus unknownNCT01827241
• An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to MetforminTerminatedNCT01816659Phase 1
• Intravesical Cidofovir for Hemorrhagic CystitisCompletedNCT01816646Phase 1
• Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRGTerminatedNCT01815346Phase 1/2
• Project Impact: A Culturally-Tailored Adherence Intervention for Latino SmokersCompletedNCT01811628
• Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation TherapyCompletedNCT01808677
• Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL AmyloidosisTerminatedNCT01807286Phase 1
• CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL)CompletedNCT01804335Phase 1
• Ask Advise Connect (AAC) Harris Heath CPRITActive, not recruitingNCT01788787
• Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by SurgeryCompletedNCT01787500Phase 1
• Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative NeoplasmCompletedNCT01787487Phase 2
• Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01787474Phase 1
• Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate CancerActive, not recruitingNCT01786265Phase 2
• Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)WithdrawnNCT01782976Phase 2
• Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast CancerTerminatedNCT01755130Not applicable
• Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)CompletedNCT01751438Phase 2
• Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase InhibitorsTerminatedNCT01751425Phase 1
• Ipilimumab and Lenalidomide in Advanced CancerCompletedNCT01750983Phase 1
• Dasatinib and Crizotinib in Advanced CancerCompletedNCT01744652Phase 1
• Phase I/II Cabazitaxel for Recurrent Malignant GliomaWithdrawnNCT01740570Phase 1/2
• Ipilimumab and Imatinib Mesylate in Advanced CancerCompletedNCT01738139Phase 1
• Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot StudyCompletedNCT01737671Early Phase 1
• Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell LymphomaTerminatedNCT01729104Phase 1
• Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid CancerActive, not recruitingNCT01709292Phase 2
• Magnetic Resonance Imaging of Gynecologic Malignancies Involving the VaginaCompletedNCT01703195Not applicable
• IADAPT-Third PhaseCompletedNCT01698762
• Domperidone in Treating Patients With Gastrointestinal DisordersActive, not recruitingNCT01696734Phase 3
• The Effect of Dexmedetomidine of the Immune SystemCompletedNCT01692210
• Three-Factor Eating Questionnaire in Measuring Eating Behavior in Adolescent and Young Adult Survivors of CNS TumorsCompletedNCT01682824
• Technology and Navigation to Improve Survivorship CareStatus unknownNCT01663870
• CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)CompletedNCT01653717Phase 1
• Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)WithdrawnNCT01649622Phase 2
• A Social Media Approach to Improve Genetic Risk Communication Phase IStatus unknownNCT01645904
• Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain MetastasesActive, not recruitingNCT01644591Phase 2
• Study of Vemurafenib, Carboplatin, and PaclitaxelCompletedNCT01636622Phase 1
• Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic SyndromeTerminatedNCT01636609Phase 1

← M.D. Anderson Cancer Center overview and focus areas